by Inteliquet | Apr 12, 2021 | Uncategorized
“COVID-19 has highlighted an important lesson for fighting cancer: The most advanced tools won’t help if they aren’t deployed widely in clinical settings.” -AI Technology Insights The pandemic uncovered various inefficiencies in healthcare. We’ve been witness to a...
by Inteliquet | Apr 6, 2021 | Uncategorized
The ACCC 47th Annual Meeting & Cancer Center Business Summit lived up to its theme of “New Models in Clinical Trials and Cancer Research.” Industry leaders came together for a virtual event to discuss software and resources built for success in a new age in cancer...
by Inteliquet | Mar 17, 2021 | biopharma, cancer, clinical data, clinical development strategy, life sciences, Uncategorized
Olga Stanko is Director of Product Development at Inteliquet™. She is responsible for working with our life sciences and healthcare clients to develop the OncWeb™ platform with features that best suit their needs. She ensures our platform works efficiently and...
by Marie E. Lamont | Mar 11, 2021 | cancer, clinical data, clinical research, Clinical Trials, EMR, patient centric, patients, Uncategorized
In 2020, we kicked off a three-part blog series examining the challenges of EMR interrogation and the best time to interrogate EMRs for clinical trial recruitment. In this third installment, we discuss the method of EMR interrogation for locating and obtaining...
by Inteliquet | Feb 5, 2021 | Uncategorized
Why Life Sciences executives are excited about the Inteliquet™ solution to faster, reliable patient matching The potential for real-world data (RWD) and real-world evidence (RWE) to accelerate clinical research and the approval of drug indications and treatments is...
by Marie E. Lamont | Dec 15, 2020 | News & Resources, Uncategorized
Contributed Commentary Since the United States’ first coronavirus case was confirmed in January 2020, COVID-19 has disrupted healthcare in myriad ways. Hospitals and healthcare practices trained their focus on acute care of infected patients. This has accelerated in...
